Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.
复制标题
DOI:
10.1176/ajp.150.1.83
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
R. Yehuda;S. Southwick;J. Krystal;D. Bremner;D. Charney;J. Mason
中科院分区:
文献类型:
--
作者:
R. Yehuda;S. Southwick;J. Krystal;D. Bremner;D. Charney;J. Mason
OBJECTIVE The authors investigated the possibility of enhanced negative feedback sensitivity of the hypothalamic-pituitary-adrenal (HPA) axis in posttraumatic stress disorder (PTSD) by using a low dose of dexamethasone. METHOD Baseline blood samples were obtained at 8:00 a.m., and 0.5 mg of dexamethasone was administered to 21 male patients with PTSD and 12 normal age-comparable men at 11:00 p.m. Cortisol and dexamethasone levels were measured 9 and 17 hours after dexamethasone administration. RESULTS After correction for differences in dexamethasone levels, the PTSD patients showed greater suppression of cortisol in response to dexamethasone than did the normal subjects. This was true even in patients meeting concurrent diagnostic criteria for major depression. CONCLUSIONS The data support earlier studies showing that HPA abnormalities in PTSD are different from those seen in depression and suggest that the low-dose dexamethasone suppression test may be a potentially useful tool for differentiating the two syndromes and further exploring differences in their pathophysiology.